Skip to content
2000
Volume 6, Issue 5
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

More recently, three novel purine nucleoside analogs, including clofarabine, nelarabine and immucillin H, have been introduced into clinical trials. These agents have different metabolic properties, novel mechanism of action, and are undergoing phase I-II clinical studies for the treatment of hematopoietic malignancies. Pharmacology and anticancer activity of PNA are the subjects of this review.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955706776876212
2006-05-01
2025-06-30
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955706776876212
Loading

  • Article Type:
    Research Article
Keyword(s): Cladribine; clofarabine; fludarabine; immucillin H; nelarabine; pentostatin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test